| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.007 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |